Vimarsana
Biggest News Aggregation in the World

Page 7 - Jonathan Cheng News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Cheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Cheng Today - Breaking & Trending Today

China Scraps Tariffs on Australian Barley - Vimarsana News

China Scraps Tariffs on Australian Barley

By Jonathan Cheng China's Ministry of Commerce said Friday that it would scrap tariffs on Australian-imported barley, in the latest sign of improving ties...

Chinese Hacking Group Breaches Commerce Secretary's Emails - Vimarsana News

Chinese Hacking Group Breaches Commerce Secretary's Emails

A China-based hacking group breached U.S. Secretary of Commerce Gina Raimondo's emails as part of a larger cyber-attack affecting over two-dozen organizations.

Repotrectinib Gets Priority Review for ROS1-Positive NSCLC - Vimarsana News

Repotrectinib Gets Priority Review for ROS1-Positive NSCLC

The FDA has accepted for Priority Review the NDA for repotrectinib to treat patients with ROS1-positive locally advanced or metastatic NSCLC.

Source: empr.com
FDA Grants Priority Review to Repotrectinib for Non-Small Cell Lung Cancer - Vimarsana News

FDA Grants Priority Review to Repotrectinib for Non-Small Cell Lung Cancer

Repotrectinib is a promising next-generation tyrosine kinase inhibitor under investigation for the treatment of ROS1-positive locally advanced or metastatic non-small cell lung cancer.

FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset - Vimarsana News

FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset

The agency accepted a New Drug Application for repotrectinib, a TKI for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.